Revolution Medicines, Inc. Zoldonrasib, a RAS (ON) G12D-selective inhibitor, demonstrated acceptable tolerability and encouraging initial antitumor activity in patients with previously treated KRAS ...

When medicine and anime combine, they create compelling stories that educate while they entertain. These 8 series are the ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

This week, archaeologists identified depictions of the Milky Way galaxy in ancient Egyptian imagery. A mathematician found a ...

A study on fasting and the ketogenic diet uncovers a newfound weakness in pancreatic tumors, making them more susceptible to ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

Researchers have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and effectively attack them. The ...

YAP, a protein known to help cancer cells survive treatment, behaves very differently in cell culture models depending on how they are grown in the lab, highlighting the importance of mimicking tumour ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge difference in treating the disease. Breast cancer is one of the few ...

This therapy "unmasks" tumor cells, MSK stated, making it easier for the patient’s own immune system to recognize and kill cancer cells. The first clinical trial testing the therapy started with ...

Annual Meeting and published in Blood Cancer Discovery, titled, “Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML ...